Results 221 to 230 of about 15,045 (253)

Assessing the quality of antimalarial drugs in Equatorial Guinea: a follow-up study. [PDF]

open access: yesBMJ Glob Health
Kaur H   +8 more
europepmc   +1 more source

Mapping Plasmodium falciparum mutations in Africa: A critical review of emerging drug resistance and implications for malaria control.

open access: yesInt J Infect Dis
Gashema P   +10 more
europepmc   +1 more source

Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance. [PDF]

open access: yesLancet Infect Dis
Ishengoma DS   +20 more
europepmc   +1 more source

AMODIAQUINE AGRANULOCYTOSIS

Medical Journal of Australia, 1977
A case of profound neutropenia and severe infection after the administration of amodiaquine is presented. The recommended dose for malaria prophylaxis was administered.
P, Gillespie, F, Wagner
openaire   +2 more sources

Amodiaquine Ocular Changes

Archives of Ophthalmology, 1982
A 34-year-old man ingested more then 250 g of amodiaquine hydrochloride (for pain) during one year and was noted to have diffuse conjunctival, corneal, and skin changes and also abnormal results from retinal function tests. Ultrastructural examination of corneal and conjunctival biopsy specimens revealed intralysosomal membranous and amorphous ...
W. Richard Green   +4 more
openaire   +2 more sources

Amodiaquine as a prodrug: Importance of metabolite(s) in the antimalarial effect of amodiaquine in humans

Life Sciences, 1985
Existing analytical methods for assaying the 4-aminoquinoline antimalarial amodiaquine in body fluids are nonspecific and obscure the fact that little or no amodiaquine is present in the blood of dosed persons. We have isolated four metabolites of amodiaquine. The two major metabolites have been identified; one is desethylamodiaquine, and the other has
Ira K. Schwartz   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy